Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a live attenuated vaccine candidate for equid alphaherpesvirus 1 control: a step towards efficient protection.

Frontiers in immunology - 1 Jan 2024

Hu Yue, Wu Guiling, Jia Qinrui, Zhang Baozhong, Sun Wencheng, Sa Ruixue, Zhang Siyu, Cai Weifan, Jarhen, Ran Duoliang, Liu Jianhua

Abstract excerpt

Equid alphaherpesvirus 1 (EqAHV1) is a viral pathogen known to cause respiratory disease, neurologic syndromes, and abortion storms in horses. Currently, there are no vaccines that provide complete protection against EqAHV1. Marker vaccines and the differentiation of infected and vaccinated animals (DIVA) strategy are effective for preventing and controlling outbreaks but have not been used for the prevention of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesviridae Infections
Share to Herpesvirus 1, Equid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Horse Diseases

Share to Horses

Share to Mesocricetus

Share to Vaccines, Attenuated

Share to Viral Envelope Proteins

Share to Viral Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 39021566
DOI: 10.3389/fimmu.2024.1408510
PMCID: PMC11252532

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a live attenuated vaccine candidate for equid alphaherpesvirus 1 control: a step towards efficient protection.PMID 39021566Read ↗

Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicitySemantic proximity Read ↗

Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All SerotypesSemantic proximity Read ↗

Equine Influenza Virus: An Old Known Enemy in the AmericasSemantic proximity Read ↗

African Horse Sickness: A Review of Current Understanding and Vaccine DevelopmentSemantic proximity Read ↗

Equine herpesvirus type 1 mutant defective in glycoprotein E gene as candidate vaccine strain.Semantic proximity Read ↗

The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horsesSemantic proximity Read ↗

VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.Semantic proximity Read ↗

Development of Equine Polyclonal Antibodies as a Broad-Spectrum Therapy Against SARS-CoV-2 VariantsSemantic proximity Read ↗

Rescue of a vaccine strain of peste des petits ruminants virus: In vivo evaluation and comparison with standard vaccineSemantic proximity Read ↗

Harnessing Attenuation-Related Mutations of Viral Genomes: Development of a Serological Assay to Differentiate between Capripoxvirus-Infected and -Vaccinated Animals.Semantic proximity Read ↗

The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.Semantic proximity Read ↗

Evolution and Divergence of H3N8 Equine Influenza Viruses Circulating in the United Kingdom from 2013 to 2015Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.